Advances in Experimental Medicine and Biology

Author(s): Pertwee RG

School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK. [email protected]

Subject: General View the study


Human tissues express cannabinoid CB(1) and CB(2) receptors that can be activated by endogenously released 'endocannabinoids' or exogenously administered compounds in a manner that reduces the symptoms or opposes the underlying causes of several disorders in need of effective therapy. Three medicines that activate cannabinoid CB(1)/CB(2) receptors are now in the clinic: Cesamet (nabilone), Marinol (dronabinol; Δ(9)-tetrahydrocannabinol (Δ(9)-THC)) and Sativex (Δ(9)-THC with cannabidiol)...

Source: Philosophical Transactions of the Royal Society B
Share Tweet

More medical studies related to General:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

Купить ковер обращайтесь
товары для взрослых